PHARMACY PRACTICE EXPERIENTIAL PROGRAMS IN THE CONTEXT OF CLINICAL EDUCATION
Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2017, Vol 9, Issue 2
Abstract
Objective: To identify studies describing and/or assessing pharmacy practice experiential programs focusing on clinical education.Methods: A systematic literature review was carried out. The databases searched included Lilacs, Medline/Pubmed, Eric and Scopus. The search strategy was devised based on a combination of subject headings related to pharmacy practice experiential programs, pharmacy education, and clinical practice in pharmacy. Two reviewers independently performed article selection, applying eligibility criteria defined. The level of agreement between the reviewers (Kappa coefficient) was calculated. Information about the clinical practice and settings used, description of pharmacy practice experiential model and type of evaluation study performed was collected from the articles selected using a pre structured form.Results: Of the 474 items retrieved in the initial search, 31 articles met the eligibility criteria. An increase in the number of publications in the 2000s was noted, predominantly (n=22, 71.0%) from North America. Pharmaceutical care was the most commonly used term to denote clinical practice in pharmacy. The practice sites ranged from hospitals (n=13, 41.9%), outpatient clinics (n=12, 38.7%), community pharmacies (n=7, 22.6%) and other community institutions (n=10, 32.3%), whereas some experiences involved a combination of these settings. The most common organizational arrangement involved pharmacists from the healthcare service as preceptors supervising students in the field, and teachers as educators, tutors and researchers within universities. In some situations, however, teachers and more advanced students acted as preceptors. Educational outcomes and/or results related to the service delivered by students and preceptors were assessed, where the quantitative method was the most frequently employed approach in both cases.Conclusion: The studies revealed that the partnership among university, health services and community is a promising initiative for improving the quality of pharmaceutical services offered to society and of pharmaceutical education.
Authors and Affiliations
Simone De AraÚjo Medina MendonÇa, Beatriz Leal Meireles, Erika LourenÇo De Freitas, Djenane Ramalho De Oliveira
Keywords
Related Articles
- EP ID EP575818
- DOI 10.22159/ijpps.2017v9i2.16247
- Views 78
- Downloads 0
ASSESS THE PREVALENCE OF RESPIRATORY PROBLEM AND KNOWLEDGE ON HEALTH EFFECTS OF PEOPLE RESIDING NEAR QUARRY
Objective: In the quarry area, there are various suspended particulate matters are mixed with the ambient air in and around. People residing near to that quarry areas are exposed to hazards through the inhalation of airb...
A SYSTEMATIC REVIEW ON INDIAN FLORAL BIODIVERSITY AS EMINENT RESERVES FOR ALTERNATIVE TREATMENT STRATEGY OF DIABETES MELLITUS
Among the most common chronic diseases in the world, Diabetes mellitus (DM) is an extremely studied and widely manifested multi-factorial disease which deliberately requires multi-modal therapeutic strategies [1]. It has...
SIMULTANEOUS ESTIMATION OF PROPAFENONE AND ITS TWO METABOLITES IN HUMAN PLASMA BY LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY LC-MS/MS
Objective: A simple, sensitive and rapid performance liquid chromatography/positive ion electrospray tandem mass spectrometry method was to be developed and validated for quantification of propafenone (PPF) and its two m...
DESIGN AND EVALUATION OF COLON SPECIFIC DRUG DELIVERY OF BUDENOSIDE
Objective: The objective of this research is to design and evaluate a colon specific drug delivery of budenoside using guar gum as enzyme dependent polymer.Methods: Matrix tablets of Budenoside were prepared by using wet...
SYNTHESIS, STRUCTURAL ELUCIDATION AND ANTIMICROBIAL EVALUATION OF 2-{4-(T-AMINO)-2-(BUT-2-YN-1-YL)}-1, 3 BENZOTHIAZOLE DERIVATIVES
Objective: A new series of 2-{4-(t-amino)-2-(but-2-yn-1-yl)}-1,3-benzothiazole derivatives, 2-[4-(pyrrolidin-1-yl)but-2-yn-1-yl]-1,3-benzothiazole (BZ2), 2-[4-(2-methylpiperidin-1-yl)but-2-yn-1-yl]-1,3-benzothiazole (BZ3...